#Investing in #Functional and #Psychedelic #Mushrooms- #Stocks to watch- (OTC: $LRSV) (OTC: $MMEDF) (OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco @NewWaveHolding @PSYBioLife @redlightholland

 #Investing in #Functional and #Psychedelic #Mushrooms- #Stocks to watch- (OTC: $LRSV) (OTC: $MMEDF) (OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco @NewWaveHolding @PSYBioLife @redlightholland

 

Point Roberts WA, Delta, BC – April 19, 2021 - Investorideas.com, a leading investor news resource covering functional mushrooms and plant-based food alternatives releases a special report on the growing dominance of both functional and psychedelic mushrooms in the current health and wellness sector, featuring Link Reservations Inc. (OTC: LRSV).  Current medicinal trends and new research point to the phenomenal promise of fungi for the future of food, medicine and technology.

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/04191LRSV-Psychedelic-Mushrooms.asp

 

Looking at just one single mushroom, Reishi, is used in many modern health and wellness products, according to Allied Market Research, “The global reishi mushroom market was valued at $3,096.9 million in 2019, and is projected to reach $5,059.4 million by 2027, registering a CAGR of 8.1% from 2021 to 2027. In 2019, the powder reishi mushroom segment accounted for the highest share in the reishi mushroom market size.”

 

Link Reservations Inc. (OTC: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets just recently announced the launch and availability to purchase  DailyLife CBD Immune, its immune boosting functional mushroom product. Featuring a combination of CBD and a spectrum of functional mushrooms (including Lion’s Mane), the tincture will be available for sale on the DailyLife CBD website.

 

“It is my pleasure to announce that we have now launched our first functional mushroom product. We have been researching the power of medicinal mushrooms for some time and it is great to be able to bring to market a product that combines the power of mushrooms with the anti-inflammatory benefits of CBD. The overall goal is to offer natural products that can strongly benefit our health and, with regards to DailyLife CBD Immune, to boost and maintain a healthy immune system,” commented Rene Lauritsen, CEO at Link Reservations Inc. “Health and wellbeing have been absolutely front of mind for everyone in the past 12 months, so creating a product that can naturally benefit people is a great achievement,” he added.

 

DailyLife CBD Immune features an organic blend of 13 different medicinal mushrooms, including Lions Mane, Turkey Tail, Chaga, Red Reishi, Cordyceps amongst others. By focusing on a variety of mushrooms, the product is able to encompass multiple immune boosting traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and 100mg of vitamin C which will add to the immune boosting benefits.

 

“We are excited with the first launch of the functional mushroom range and we look forward to see the reception while we work on the other projects in the pipeline. We look forward to sharing more developments as they arise through press releases,” ended Lauritsen.

 

Link Reservations isn’t alone in pivoting off CBD wellness products into the functional mushroom category as NEW WAVE HOLDINGS CORP. (CSE: SPOR) (OTC: TRMNF), an investment issuer that provides capital and support services recently announced the launch of its first mushroom products in a new functional mushroom collection, which will live under the Way of Will brand.

 

Way of Will, a natural wellness brand under New Wave and known for its aromatherapy-based products, revealed earlier this year that it will be introducing a new line of functional mushroom products in the upcoming months. Further to the announcement, the company is releasing the Functional Mushroom Powder and the Functional Mushroom Capsules from the collection to the U.S. market. Paving the way to a larger collection of specialty mushroom products, the mushroom powder and capsules will be the first step in Way of Will's journey into the psychedelics space.

 

The product launch, featuring a house-blend of five functional mushrooms and fungi available in both capsule and powder format, aim to naturally boost immunity. They are loaded with vitamins, nutrients, and antioxidants that support a healthy immune system. The capsules are designed with ease of consumption and convenience in mind, while the powder allows for versatile use by mixing and incorporating it into foods and beverages.

 

"Mushrooms are gaining popularity rapidly right now, but they're not a new phenomenon in food and medicine. They have been used in certain regions of the world for centuries for a plethora of health and wellness purposes," said Willie Tsang, founder and CEO of Way of Will.

 

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, recently announced that it has published a new research report on Link Reservations, Inc. (OTC PINK:LRSV).. This report carries a price target of 10 .

 

Looking at the psychedelic mushroom space, which has been mostly dominated by news on psilocybin, we are now just beginning to see growing interest in compounds other than psilocin in psychoactive mushroom strains. PsyBio Therapeutics Corp. (TSXV: PSYB), a biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health and other disorders and a leader in the field of psychedelic research and drug development, has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit, a scale-up facility managed by Lawrence Berkeley National Laboratory, a US Department of Energy national laboratory. Norbaeocystin is an analogue of psilocybin and is not a controlled substance. The Company has commenced Phase I of this process, including analytical chemistry technical transfer to establish detection methods for fermentation products and key feedstocks and metabolites.

 

As both functional and psychoactive mushrooms continue to grow in popularity, much as we have seen in the cannabis industry, infrastructure and supply chains are the next hurdle the mushroom industry must look to address. Red Light Holland Corp. (CSE: TRIP) (OTC: TRUFF), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, recently announced that its wholly-owned subsidiary, RLH Netherlands B.V., has completed the acquisition of SR Wholesale B.V., one of the Netherlands' premiere distributors for quality psychedelic truffles. In 2020, SR Wholesale generated over $2.44 Million in revenues[1], and over $822,0001 in gross profit, with approximately $400,0001 of cash and working capital currently on hand. SR Wholesale also distributes popular CBD products, cannabis seeds, smart shop items, and headshop products, among others. SR Wholesale has established a distribution network of over 400 companies that sell their products across Europe, including working with sub-distributors which provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.

 

Founded in 2017, SR Wholesale has grown to become one of the most recognized and trusted distribution companies in the Netherlands. In connection with the Acquisition, Red Light Holland announced that Mr. Shai Ramsahai, Founder of SR Wholesale, has joined the Red Light Holland team on closing as Vice-President to oversee the integration of SR Wholesale into the Red Light Holland ecosystem, and grow the distribution business for Red Light Holland globally. The acquisition will create immediate synergies and enhance Red Light Holland's growth and expansion strategy.

 

"The acquisition of SR Wholesale marks the latest step in the Company's growth and expansion strategy, as we continue to move forward with a positive business outlook focused on achieving revenue growth, profitability and value creation for our shareholders. We expect this transaction to serve as a launchpad for Red Light Holland to broaden operations, create new homes for our iMicrodose packs and build brand exposure into multiple European markets. Others companies in the sector can keep telling people or assuming how people should consume psilocybin years from now, while we will continue offering people what they want right now, while concentrating on immediate revenue, profit and growth" said Todd Shapiro, Chief Executive Officer and Director of the Company. "We are quite thrilled, after months of tough negotiations and careful due diligence, to move forward as the largest legal psychedelic distribution publicly traded company in the world.[2] As well, we are truly so pleased to work closely with Mr. Shai Ramsahai, who is one of the brightest, most determined and likeable entrepreneurs I've ever come across. And he is an absolute legend in the Netherlands!"

 

Other companies in the psychedelic mushroom sector include MindMed (OTC: MMEDF), a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a  drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The Company is expanding its reach in psychedelic  research and recently announced,” MindMed Announces the Publication of New Data on Personalized MDMA Dosing.”

 

According to Fortune Business Insights, “The global mushroom market was valued at 12.74 million tons (MT) in 2018 and is projected to reach 20.84 million tons (MT) by 2026, exhibiting a CAGR of 6.41% in the forecast period.”

 

As new research and developments provide mounting evidence supporting the use of functional and psychedelic mushrooms as sustainable, healthy medical and food alternatives, it seems the fantastic world of fungi will be the topic of much discussion for years to come.  

 

About Investorideas.com - Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye

 

Disclaimer/Disclosure :Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring LRSV is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Contact Investorideas.com

800-665-0411

 

Health, Wellness and Sustainability Stocks Research and News at Investorideas.com - investing ideas for a better world

Like Health, Wellness and Sustainability Stocks? View our LOHAS Stocks Directory

 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

 

#Mushrooms on the Brain: (OTC: $LRSV) (OTC: $MMEDF) (OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco @NewWaveHolding @PSYBioLife @redlightholland

 #Mushrooms on the Brain: (OTC: $LRSV) (OTC: $MMEDF) (OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco @NewWaveHolding @PSYBioLife @redlightholland

 

Functional and #Psychedelic Mushrooms Continue to Dominate #Health and #Medical Trends 

 

Point Roberts WA, Delta, BC – April 16, 2021 - Investorideas.com, a leading investor news resource covering functional mushrooms and plant-based food alternatives releases a special report on the growing dominance of both functional and psychedelic mushrooms in the current health and wellness sector, featuring Link Reservations Inc. (OTC: LRSV).  Current medicinal trends and new research point to the phenomenal promise of fungi for the future of food, medicine and technology.

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/04161LRSV-Psychedelic-Mushrooms.asp

 

Looking at just one single mushroom, Reishi, is used in many modern health and wellness products, according to Allied Market Research, “The global reishi mushroom market was valued at $3,096.9 million in 2019, and is projected to reach $5,059.4 million by 2027, registering a CAGR of 8.1% from 2021 to 2027. In 2019, the powder reishi mushroom segment accounted for the highest share in the reishi mushroom market size.”

 

Link Reservations Inc. (OTC: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets just recently announced the launch and availability to purchase  DailyLife CBD Immune, its immune boosting functional mushroom product. Featuring a combination of CBD and a spectrum of functional mushrooms (including Lion’s Mane), the tincture will be available for sale on the DailyLife CBD website.

 

“It is my pleasure to announce that we have now launched our first functional mushroom product. We have been researching the power of medicinal mushrooms for some time and it is great to be able to bring to market a product that combines the power of mushrooms with the anti-inflammatory benefits of CBD. The overall goal is to offer natural products that can strongly benefit our health and, with regards to DailyLife CBD Immune, to boost and maintain a healthy immune system,” commented Rene Lauritsen, CEO at Link Reservations Inc. “Health and wellbeing have been absolutely front of mind for everyone in the past 12 months, so creating a product that can naturally benefit people is a great achievement,” he added.

 

DailyLife CBD Immune features an organic blend of 13 different medicinal mushrooms, including Lions Mane, Turkey Tail, Chaga, Red Reishi, Cordyceps amongst others. By focusing on a variety of mushrooms, the product is able to encompass multiple immune boosting traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and 100mg of vitamin C which will add to the immune boosting benefits.

 

“We are excited with the first launch of the functional mushroom range and we look forward to see the reception while we work on the other projects in the pipeline. We look forward to sharing more developments as they arise through press releases,” ended Lauritsen.

 

Link Reservations isn’t alone in pivoting off CBD wellness products into the functional mushroom category as NEW WAVE HOLDINGS CORP. (CSE: SPOR) (OTC: TRMNF), an investment issuer that provides capital and support services recently announced the launch of its first mushroom products in a new functional mushroom collection, which will live under the Way of Will brand.

 

Way of Will, a natural wellness brand under New Wave and known for its aromatherapy-based products, revealed earlier this year that it will be introducing a new line of functional mushroom products in the upcoming months. Further to the announcement, the company is releasing the Functional Mushroom Powder and the Functional Mushroom Capsules from the collection to the U.S. market. Paving the way to a larger collection of specialty mushroom products, the mushroom powder and capsules will be the first step in Way of Will's journey into the psychedelics space.

 

The product launch, featuring a house-blend of five functional mushrooms and fungi available in both capsule and powder format, aim to naturally boost immunity. They are loaded with vitamins, nutrients, and antioxidants that support a healthy immune system. The capsules are designed with ease of consumption and convenience in mind, while the powder allows for versatile use by mixing and incorporating it into foods and beverages.

 

"Mushrooms are gaining popularity rapidly right now, but they're not a new phenomenon in food and medicine. They have been used in certain regions of the world for centuries for a plethora of health and wellness purposes," said Willie Tsang, founder and CEO of Way of Will.

 

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, recently announced that it has published a new research report on Link Reservations, Inc. (OTC PINK:LRSV).. This report carries a price target of 10 .

 

Looking at the psychedelic mushroom space, which has been mostly dominated by news on psilocybin, we are now just beginning to see growing interest in compounds other than psilocin in psychoactive mushroom strains. PsyBio Therapeutics Corp. (TSXV: PSYB), a biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health and other disorders and a leader in the field of psychedelic research and drug development, has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit, a scale-up facility managed by Lawrence Berkeley National Laboratory, a US Department of Energy national laboratory. Norbaeocystin is an analogue of psilocybin and is not a controlled substance. The Company has commenced Phase I of this process, including analytical chemistry technical transfer to establish detection methods for fermentation products and key feedstocks and metabolites.

 

As both functional and psychoactive mushrooms continue to grow in popularity, much as we have seen in the cannabis industry, infrastructure and supply chains are the next hurdle the mushroom industry must look to address. Red Light Holland Corp. (CSE: TRIP) (OTC: TRUFF), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, recently announced that its wholly-owned subsidiary, RLH Netherlands B.V., has completed the acquisition of SR Wholesale B.V., one of the Netherlands' premiere distributors for quality psychedelic truffles. In 2020, SR Wholesale generated over $2.44 Million in revenues[1], and over $822,0001 in gross profit, with approximately $400,0001 of cash and working capital currently on hand. SR Wholesale also distributes popular CBD products, cannabis seeds, smart shop items, and headshop products, among others. SR Wholesale has established a distribution network of over 400 companies that sell their products across Europe, including working with sub-distributors which provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.

 

Founded in 2017, SR Wholesale has grown to become one of the most recognized and trusted distribution companies in the Netherlands. In connection with the Acquisition, Red Light Holland announced that Mr. Shai Ramsahai, Founder of SR Wholesale, has joined the Red Light Holland team on closing as Vice-President to oversee the integration of SR Wholesale into the Red Light Holland ecosystem, and grow the distribution business for Red Light Holland globally. The acquisition will create immediate synergies and enhance Red Light Holland's growth and expansion strategy.

 

"The acquisition of SR Wholesale marks the latest step in the Company's growth and expansion strategy, as we continue to move forward with a positive business outlook focused on achieving revenue growth, profitability and value creation for our shareholders. We expect this transaction to serve as a launchpad for Red Light Holland to broaden operations, create new homes for our iMicrodose packs and build brand exposure into multiple European markets. Others companies in the sector can keep telling people or assuming how people should consume psilocybin years from now, while we will continue offering people what they want right now, while concentrating on immediate revenue, profit and growth" said Todd Shapiro, Chief Executive Officer and Director of the Company. "We are quite thrilled, after months of tough negotiations and careful due diligence, to move forward as the largest legal psychedelic distribution publicly traded company in the world.[2] As well, we are truly so pleased to work closely with Mr. Shai Ramsahai, who is one of the brightest, most determined and likeable entrepreneurs I've ever come across. And he is an absolute legend in the Netherlands!"

 

Other companies in the psychedelic mushroom sector include MindMed (OTC: MMEDF), a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a  drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The Company is expanding its reach in psychedelic  research and recently announced,” MindMed Announces the Publication of New Data on Personalized MDMA Dosing.”

 

According to Fortune Business Insights, “The global mushroom market was valued at 12.74 million tons (MT) in 2018 and is projected to reach 20.84 million tons (MT) by 2026, exhibiting a CAGR of 6.41% in the forecast period.”

 

As new research and developments provide mounting evidence supporting the use of functional and psychedelic mushrooms as sustainable, healthy medical and food alternatives, it seems the fantastic world of fungi will be the topic of much discussion for years to come.  

 

About Investorideas.com - Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye

 

Disclaimer/Disclosure :Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring LRSV is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Contact Investorideas.com

800-665-0411

 

Health, Wellness and Sustainability Stocks Research and News at Investorideas.com - investing ideas for a better world

Like Health, Wellness and Sustainability Stocks? View our 

LOHAS Stocks Directory

 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

Investorideas.com - Cannabis Stock News: True Leaf (CSE: MJ) Receives Preliminary Subdivision Approval for the Okanagan's First Cannabis Business Park

Investorideas.com - Cannabis Stock News: True Leaf (CSE: MJ) Receives Preliminary Subdivision Approval for the Okanagan's First Cannabis Business Park

Investor Ideas #Potcast 553, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (TSX: $APHA.TO) (NASDAQ: $APHA), (OTC: $VSYM), (TSXV: $VIS.V)

 

Investor Ideas #Potcast 553, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (TSX: $APHA.TO) (NASDAQ: $APHA), (OTC: $VSYM), (TSXV: $VIS.V)

 

Delta, Kelowna, BC, April 15, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/041521-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/04151XTRX-APHA-VSYM-VIS.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

In today’s podcast we look at a few public company announcements.

 

Aphria Inc. (TSX: APHA) (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company, today announced that its holders of Aphria's common shares at the special meeting of Aphria Shareholders approved the previously announced arrangement under the Business Corporations Act (Ontario), pursuant to which, among other things, Tilray, Inc. will acquire all of the issued and outstanding Aphria Shares. Pursuant to the Arrangement, the Aphria Shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria Share held, while holders of Tilray Shares will continue to hold their Tilray Shares with no adjustment to their holdings.

 

The special resolution approving the Arrangement was required to be passed by at least two-thirds (66 2/3%) of the votes cast at the Meeting by the Aphria Shareholders voting virtually or represented by proxy at the Meeting. A total of 108,409,367 Aphria Shares were represented by proxy at the Meeting, representing approximately 34.43% of the issued and outstanding Aphria Shares. Of the total Aphria Shares voted, 99.38% voted FOR the Arrangement.

 

Irwin D. Simon, Aphria's Chairman and Chief Executive Officer, who will hold these same roles with the Combined Company, commented, "I want to thank all Aphria Shareholders for voting and approving the Arrangement. We appreciate their support, as we believe the business combination will create a Combined Company with a strong financial profile, low-cost production, market share leading brands, distribution network and unique partnerships,.The Combined Company will  be increasingly well positioned to deliver a sustainable attractive return for our combined shareholder base."

 

Closing of the Arrangement remains subject to certain customary closing conditions, including court approval and the approval of Tilray Stockholders.

 

View Systems, Inc.’s (OTC:VSYM), Sannabis S.A.S. announced the approval by an inspector from the Colombian Institute of Agriculture (ICA) of their Seed Bank Facilities in Popayán- CAUCA, Colombia, historically the country’s top marijuana growing region. The area is known for its unique landrace strains that have been sought after for many years by European seed banks due to their unique properties. These approvals allow for the commercialization of cannabis seeds certified by the Sannabis Seed Bank.

 

Yesterday, the Ministry of Agriculture’s ICA performed a site visit at Sannabis Seed Bank Facilities for approvals to register as a producer of certified seeds, and to conduct Agronomic Evaluation Studies (PEA). Sannabis is happy to report that the ICA inspector has approved both, now they must wait for a final resolution from the Ministry of Agriculture to be issued before they can begin Agronomic Evaluation Studies. They were approved to study Psychoactive (>1% THC) and Non-Psychoactive (<1% THC) marijuana strains. Studies will begin with their University partners to certify the first 10 strains, including one to produce hemp building materials, such as hemp roof tiles Sannabis has developed along with a local University which have passed durability tests. These studies are necessary to be able to file a patent on these tiles.

 

To see a copy of the reports approving the Seed Bank Facilities, click here.

 

The phytosanitary studies require them to grow a test batch and measure its characteristics before coming to market in order to certify its genetics. Sannabis has registered Colombian Landrace Strains from the CAUCA department including Punto Rojo and Mango Biche.

 

As new countries legalize marijuana, they will need to source certified genetics from a national seed registrar such as Colombia’s ICA. Sannabis is in talks with several parties interested in working with them and will make announcements accordingly. The Ministry of Agriculture is not accepting new applications for Seed Use Licenses as of December 31, 2018.

 

“These approvals, and subsequent Seed Use License, will allow us to forge relationships with the many global players looking to enter the legal marijuana industry in their home countries,” stated John Campo, President of View Systems, Inc. and co-founder of Sannabis S.A.S.

 

“We’ve put many years of hard work towards achieving this goal and are ready to start providing certified genetics possible to customers around the World,” commented Juan Paulo Guzman, Director and co-founder of Sannabis S.A.S.

 

Last year, Sannabis was issued a Fabrication license, click here to see their GRANTED Fabrication and Export License for cannabis derivatives. Sannabis also received notice from the Ministry of Justice concerning their cultivation licenses, they expect to have those licenses issued once the Ministry’s minor requests have been satisfied.

 

Visionstate Corp. (TSX-V: VIS) announced that it has created a new corporate entity named NEXT Vision Inc., a wholly owned division of Visionstate Corp., to develop Internet of Things (“IoT”) technology for the cannabis sector. By incorporating the Company’s solid knowhow from years developing, executing and selling software solutions for any kind of facility, Visionstate identified a need in facilities that grow and harvest cannabis, and to that end has landed a $500,000 contract.

 

NEXT Vision Inc. will leverage off the IoT platform for the facilities management sector to create new industry sectors.

 

Visionstate CEO John Putters explains, “There is no question that IoT technology is increasingly becoming critical to a corporation’s operations. Whether it’s analytics, predictive maintenance, or introducing new efficiencies in operations, IoT has demonstrated returns on investment. For licenced producers, the higher the crop’s quality coupled with cost-effective solutions, the better it is for the producer overall. We are focussing our technology on bringing about those positive results.”

 

Recently the cannabis sector has experienced a resurgence of activity as speculation mounts that the US will likely legalize or decriminalize cannabis at a federal level. Meanwhile, the cannabis sector has proven to be immune from the effects of COVID-19, witnessing increased sales and revenues despite the lockdowns that have occurred across Canada.

 

The inaugural contract provides NEXT Vision Inc. the ability to develop a tailored IoT solution for the cannabis sector. It includes introducing new sensor equipment, designing communication protocols between sensors, and developing robust data and analytics that provide insight into the efficiency of operations. Monitoring processes and equipment within larger licenced producers will include lighting, heat, and other environmental conditions, as well as standard procedures that are required to be met by the producers.

 

BC Hop Company Ltd. announced that it has successfully closed a non-brokered 100% acquisition of Flow Scientific Ltd.

 

Flow Scientific has been paving the way in the terpene industry since 2016 by creating authentic products that are of the highest quality in their raw form. Flow Scientific is the innovative secret behind the custom aroma, flavour and differentiation of dozens of consumer-packaged goods in the Cannabis 2.0 and 3.0 marketplace. Leading Canadian and American cannabis and agri-food companies rely on Flow for their innovation and reliability. Leading the industry with transparent and full disclosure on ingredients, Flow takes the fear out of inquiries by Health Canada or other oversight agencies with their all-natural botanically derived terpenes.

 

"As part of BC Hop Company's ongoing expansion beyond hops into industrial hemp, we are thrilled to bring the Flow Scientific team into the growing BC Hop Company Ltd. family. By combining forces, we are taking our partnership in hemp derived terpenes to the next level. We are excited about our ability to serve not only the Canadian brewing, cannabis and agri-food market, but also to serve emerging terpene markets worldwide." commented CEO, Dwayne Stewart.

 

Terpenes are nature's flavour and aroma creators and are a critical part of the product experience for consumers. Naturally derived terpenes are critical to the effectiveness of recreational and medical cannabis products, as well as other consumer packaged goods categories. This acquisition significantly expands BC Hop Company's portfolio and potential in this new and growing market.

 

Once again, today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory